HomeATOS • NASDAQ
add
Atossa Therapeutics Inc
Previous close
$1.42
Day range
$1.41 - $1.51
Year range
$0.59 - $2.31
Market cap
188.03M USD
Avg Volume
2.80M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.02M | 10.83% |
Net income | -7.75M | -3.51% |
Net profit margin | — | — |
Earnings per share | -0.06 | 0.00% |
EBITDA | -9.00M | -10.68% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 88.46M | -20.23% |
Total assets | 96.25M | -22.08% |
Total liabilities | 5.24M | -5.96% |
Total equity | 91.02M | — |
Shares outstanding | 125.30M | — |
Price to book | 1.95 | — |
Return on assets | -22.78% | — |
Return on capital | -23.83% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -7.75M | -3.51% |
Cash from operations | -5.57M | -23.17% |
Cash from investing | 0.00 | 100.00% |
Cash from financing | 0.00 | — |
Net change in cash | -5.57M | 13.99% |
Free cash flow | -3.45M | -62.44% |
About
Founded
2008
Headquarters
Website
Employees
12